Ligand validation:5QS7

JMM: [4-(cyclopropanecarbonyl)piperazin-1-yl](furan-2-yl)methanone

JMM is a Ligand Of Interest in 5QS7 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QS7_JMM_A_301	0%	37%	0.622	0.279	1.73	0.84	2	-	0	0	100%	0.44
5QRH_JMM_A_306	2%	21%	0.328	0.625	2.35	1.16	4	2	0	0	100%	0.84
5R4V_JMM_A_1201	78%	19%	0.111	0.953	2.05	1.6	4	2	3	0	100%	1
5SN7_JMM_B_501	65%	31%	0.143	0.947	1.07	1.79	1	4	0	0	100%	0.31
5QJ7_JMM_A_304	58%	21%	0.122	0.9	2.47	1.03	5	1	0	0	100%	0.78
5S9U_JMM_A_508	15%	47%	0.219	0.78	0.96	1.1	2	1	0	0	100%	0.68
5SDJ_JMM_A_801	11%	46%	0.235	0.753	0.9	1.2	2	3	0	0	100%	0.9

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.